Powder: -20°C for 3 years | In solvent: -80°C for 2 years
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide inhibits multidrug resistance protein (MRP1).
説明 | 3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide inhibits multidrug resistance protein (MRP1). |
In vitro | LY402913 demonstrated reversal of MRP1-mediated drug resistance (in the presence of a sublethal dose of doxorubicin) in the MRP1-transfected cell line, HeLa-T5, EC50 = 0.90[1]. |
分子量 | 533.96 |
分子式 | C28H24ClN3O6 |
CAS No. | 246238-55-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 55 mg/mL (103 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide 246238-55-1 Immunology/Inflammation MRP LY402913 Inhibitor inhibitor inhibit